FDA’s Bond Increases Intra-Agency Liaison Role
This article was originally published in The Pink Sheet Daily
Executive Summary
FDA Director of Scientific Policy Development Susan Bond will assume a greater role in intra-agency communications.
You may also be interested in...
FDA External Relations Head Pitts Will Leave Agency June 18
Associate Commissioner for External Relations Peter Pitts will join the public relations firm Manning, Selvage & Lee as VP-health affairs. During his 14-month tenure at FDA, the agency adopted a more aggressive communications approach.
Crawford Will Lead A Reorganized FDA As McClellan Leaves For CMS
FDA is implementing a three-deputy commissioner structure on an acting basis to ensure a smooth transition. Selection of a permanent commissioner is unlikely before the November elections.
Pink Sheet Podcast: Relyvrio And Public Promises, Allergy Biomarker Adcomms, PMDA In The USA
Pink Sheet reporters and editor discuss the implications of Amylyx following through on its pledge to remove Relyvrio from the market after its trial failed, an FDA idea to bring potential biomarkers for promising allergy and asthma treatments to advisory committees, and Japan’s PMDA opening an office in Washington D.C.